Pubertal Development and Timing in Pediatric Health

Pubertal development encompasses the physical, hormonal and psychosocial transformations that mark the transition from childhood to reproductive maturity. Core processes include gonadarche and adrenarche, which drive sex steroid production and secondary sexual characteristics, and culminate in events such as menarche and spermarche. Timing and tempo vary widely between individuals and are shaped by genetic predisposition, nutritional status, psychosocial stressors and exposure to endocrine-disrupting chemicals. Secular trends indicate a shift towards earlier maturation in girls and more heterogeneity in boys, with implications for long-term cardiometabolic, reproductive and mental health. Early or delayed puberty is linked to adverse outcomes including obesity, type 2 diabetes, cardiovascular disease and mood disorders. Accurate measurement through Tanner staging, age at peak height velocity and self-reported milestones underpins both epidemiological research and clinical management. Understanding normative and pathological trajectories is essential to inform public health strategies, guide therapeutic interventions and mitigate lifelong consequences of atypical pubertal timing.

Research from Nature Portfolio

Recent investigations have quantitatively compared nine indicators of pubertal timing in large birth cohorts, demonstrating that ages at breast development, pubic hair appearance and voice breaking exhibit substantial inter-individual variation yet share strong phenotypic and genetic correlations. Integration of genetic risk scores for age at menarche and voice breaking has revealed common heritable influences across multiple pubertal markers and linked higher childhood fat and lean mass to earlier pubertal onset. In a foundational population-based analysis, recalled timing of puberty was associated with elevated lifetime risks of type 2 diabetes, cardiovascular disease, diverse cancers and reproductive disorders in both sexes, underscoring the far-reaching health consequences of early or late pubertal initiation. These studies illustrate the value of combining phenotypic, genomic and longitudinal data to refine definitions of normal and pathological maturation.

Pubertal Development and Timing in Pediatric Health publication trend

The graph below shows the total number of articles in pubertal development and timing in pediatric health across all publications each year (not limited to Nature Index journals).

Technical terms

Gonadarche: Activation of the hypothalamic–pituitary–gonadal axis leading to gonadal maturation and sex steroid production.

Adrenarche: Maturation of the adrenal cortex resulting in increased secretion of androgens such as dehydroepiandrosterone.

Tanner stage: Standardised staging system for assessing external physical development during puberty.

Peak height velocity: Maximum rate of increase in stature during the adolescent growth spurt.

Menarche: First menstrual bleeding, signalling onset of reproductive capability in females.

Precocious puberty: Onset of secondary sexual characteristics before age eight in girls or nine in boys due to early hypothalamic–pituitary–gonadal activation.

Genetic risk score (GRS): Composite metric of multiple inherited variants used to estimate an individual’s predisposition to a trait.

Endocrine disruptors: Exogenous chemicals that interfere with hormone synthesis, metabolism or receptor signalling, potentially altering pubertal timing.

References

1. Metabolic characteristics and pathogenesis of precocious puberty in girls: the role of perfluorinated compounds. BMC Medicine (2023).
2. Gut microbiome combined with metabolomics reveals biomarkers and pathways in central precocious puberty. Journal of Translational Medicine (2023).
3. Evaluation and comparison of nine growth and development-based measures of pubertal timing. Communications Medicine (2024).
4. Puberty timing associated with diabetes, cardiovascular disease and also diverse health outcomes in men and women: the UK Biobank study. Scientific Reports (2015).
5. Trends in the Incidence of Central Precocious Puberty and Normal Variant Puberty Among Children in Denmark, 1998 to 2017. JAMA Network Open (2020).